Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Diominic DC Tablet may be taken with or without food, but it is better to take it at a fixed time. Take it with food if stomach upset occurs.
Diominic DC Tablet is a combination of two medicines: Chlorpheniramine and Phenylephrine which relieve cold symptoms. Chlorpheniramine is an antiallergic which relieves allergy symptoms like runny nose, watery eyes and sneezing. Phenylephrine is a decongestant which narrows the small blood vessels providing relief from congestion or stuffiness in the nose.
Diominic DC Tablet may cause excessive drowsiness and calmness with alcohol.
WEIGH RISKS VS BENEFITS
Diominic DC Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Diominic DC Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Diominic DC Tablet may make you feel dizzy, sleepy, tired, o
r decrease alertness. If this happens, do not drive.
Diominic DC Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Diominic DC Tablet may not be needed in these patients. Please consult your doctor.
Use of Diominic DC Tablet may cause excessive sleepiness in patients with end stage kidney disease.
Diominic DC Tablet should be used with caution in patients w
ith liver disease. Dose adjustment of Diominic DC Tablet may be needed. Please consult your doctor.
“The following are the results of on-going survey on 1mg.com for Diominic DC Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 6th Feb 2018.